In a clinical setting, sensible perspiration is not generally considered, but may be significant in a patient with severe sepsis.[ 4 ] GDFT is a term that describes the protocolled use of cardiac output (CO) and related parameters as end-points for the administration of fluids and/or inotropic therapies with the objective of optimizing organ perfusion with improvement of surgical outcome.[ 5 ]
← all excerpts
Has goal directed fluid therapy and glycocalyx a role in enhanced recovery after anesthesia?
1
—
—